Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer
- PMID: 23117294
- DOI: 10.1007/s10156-012-0485-5
Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer
Abstract
Human papillomavirus (HPV) is the most important etiological factor for cervical cancer. A recent study demonstrated that more than 20 HPV types were thought to be oncogenic for uterine cervical cancer. Notably, more than one-half of women show cervical HPV infections soon after their sexual debut, and about 90 % of such infections are cleared within 3 years. Immunity against HPV might be important for elimination of the virus. The innate immune responses involving macrophages, natural killer cells, and natural killer T cells may play a role in the first line of defense against HPV infection. In the second line of defense, adaptive immunity via cytotoxic T lymphocytes (CTLs) targeting HPV16 E2 and E6 proteins appears to eliminate cells infected with HPV16. However, HPV can evade host immune responses. First, HPV does not kill host cells during viral replication and therefore neither presents viral antigen nor induces inflammation. HPV16 E6 and E7 proteins downregulate the expression of type-1 interferons (IFNs) in host cells. The lack of co-stimulatory signals by inflammatory cytokines including IFNs during antigen recognition may induce immune tolerance rather than the appropriate responses. Moreover, HPV16 E5 protein downregulates the expression of HLA-class 1, and it facilitates evasion of CTL attack. These mechanisms of immune evasion may eventually support the establishment of persistent HPV infection, leading to the induction of cervical cancer. Considering such immunological events, prophylactic HPV16 and 18 vaccine appears to be the best way to prevent cervical cancer in women who are immunized in adolescence.
Similar articles
-
Immunity to oncogenic human papillomaviruses.Adv Cancer Res. 2001;82:205-38. doi: 10.1016/s0065-230x(01)82007-8. Adv Cancer Res. 2001. PMID: 11447764 Review.
-
Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.J Virol. 2005 Jun;79(11):6741-50. doi: 10.1128/JVI.79.11.6741-6750.2005. J Virol. 2005. PMID: 15890912 Free PMC article.
-
Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6.Cancer Res. 2004 Aug 1;64(15):5449-55. doi: 10.1158/0008-5472.CAN-04-0831. Cancer Res. 2004. PMID: 15289354
-
Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.Int J Cancer. 2007 Dec 15;121(12):2711-5. doi: 10.1002/ijc.23035. Int J Cancer. 2007. PMID: 17724722
-
[Immune response in cervical cancer. Strategies for the development of therapeutic vaccines].Rev Med Inst Mex Seguro Soc. 2015;53 Suppl 2:S206-11. Rev Med Inst Mex Seguro Soc. 2015. PMID: 26462518 Review. Spanish.
Cited by
-
Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyond.Am Soc Clin Oncol Educ Book. 2015:e299-309. doi: 10.14694/EdBook_AM.2015.35.e299. Am Soc Clin Oncol Educ Book. 2015. PMID: 25993189 Free PMC article.
-
Evaluating the quality of HPV vaccine-related information on the Portuguese Internet.Hum Vaccin Immunother. 2022 Nov 30;18(6):2104571. doi: 10.1080/21645515.2022.2104571. Epub 2022 Jul 26. Hum Vaccin Immunother. 2022. PMID: 35881926 Free PMC article.
-
NK Cell Regulation in Cervical Cancer and Strategies for Immunotherapy.Cells. 2021 Nov 10;10(11):3104. doi: 10.3390/cells10113104. Cells. 2021. PMID: 34831327 Free PMC article. Review.
-
Pathogenesis, diagnosis and therapeutic strategies in WHIM syndrome immunodeficiency.Expert Opin Orphan Drugs. 2017;5(10):813-825. doi: 10.1080/21678707.2017.1375403. Epub 2017 Sep 25. Expert Opin Orphan Drugs. 2017. PMID: 29057173 Free PMC article.
-
Androgens in cervical cancer: Their role in epidemiology and biology.iScience. 2024 Jun 1;27(7):110155. doi: 10.1016/j.isci.2024.110155. eCollection 2024 Jul 19. iScience. 2024. PMID: 39021790 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials